Publications
132
Citations
7,486
Est. group size
~1
Recurring co-author estimate
Active years
47
Publishing since 1979
Stephen J. Kolb's research focuses on neuromuscular and motor neuron diseases, particularly amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). His work involves identifying biomarkers, tracking disease progression, and using patient-derived stem cell models (such as induced pluripotent stem cells, or iPSCs) to study disease mechanisms and evaluate potential treatments. This research combines clinical studies, laboratory experiments, and computational analysis of large patient datasets.
Publication output rose from around 8 papers per year in 2017 to a peak of 14 in 2021, then declined to roughly 4-8 papers per year in recent years, suggesting a slowing trend after 2021.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls
Nature Communications · 2024
- Machine learning-enhanced electrical impedance myography to diagnose and track spinal muscular atrophy progression
Physiological Measurement · 2024
- Spinal muscular atrophy
Elsevier eBooks · 2024
- List of Contributors
Elsevier eBooks · 2024
- Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
Journal of Neuromuscular Diseases · 2023
- Heterogeneous splicing patterns resulting from <i>KIF5A</i> variants associated with amyotrophic lateral sclerosis
Human Molecular Genetics · 2023
- Impact of Nusinersen treatment on quality of life in adult patients with Spinal Muscular Atrophy (P3-8.010)
Neurology · 2023
- Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines
Nature Neuroscience · 2022
- Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data
Nature Computational Science · 2022
- PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in C9ORF72-ALS/FTD
Acta Neuropathologica · 2022
- <scp>CuATSM</scp> effectively ameliorates <scp>ALS</scp> patient astrocyte‐mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis
Glia · 2022
- EphA4 targeting agents protect motor neurons from cell death induced by amyotrophic lateral sclerosis -astrocytes
iScience · 2022
- Update on Biomarkers in Spinal Muscular Atrophy
Biomarker Insights · 2021
- A review and analysis of the clinical literature on Charcot–Marie–Tooth disease caused by mutations in neurofilament protein L
Cytoskeleton · 2021
- Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts
Neurobiology of Aging · 2021
- Neurology×18
- Elsevier eBooks×5
- Journal of Neuromuscular Diseases×4
- Muscle & Nerve×4
- Annals of Clinical and Translational Neurology×2
- Sarah Heintzman
Medicine · The Ohio State University
- Kelly Rich
Medicine · The Ohio State University
- Sara K. Custer
Medicine · Indiana University
- Kathrin Meyer
Medicine · The Ohio State University
- Megan A. Waldrop
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile